U.S. pharma huge copyright scrapped two experimental weight loss capsules past year—a after-daily pill, lotiglipron, due to elevated liver enzymes plus a two times-daily pill, danuglipron, on account of powerful Uncomfortable side effects—but CEO Albert Bourla has stated the company is decided to “Perform and earn” in the obesity space As w